Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Visualization of activated macrophages using a translocator protein ligand, 18F-FEDAC, in a rheumatoid arthritis model

Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, Lin Xie, June-Key Chung, Keon Wook Kang, Ming-Rong Zhang and Gi Jeong Cheon
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 62;
Seock-Jin Chung
8Tumor Biology Program, Seoul National University Seoul Korea, Republic of
3Cancer Research Institute, Seoul National University Seoul Korea, Republic of
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hai-Jeon Yoon
4Department of Nuclear medicine Ewha Womans University School of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyewon Youn
3Cancer Research Institute, Seoul National University Seoul Korea, Republic of
9Tumor Microenvironment Global Core Research Center, Seoul National University Seoul Korea, Republic of
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
2Cancer Imaging Center, Seoul National University Cancer Hospital Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mi Jeong Kim
9Tumor Microenvironment Global Core Research Center, Seoul National University Seoul Korea, Republic of
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
3Cancer Research Institute, Seoul National University Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun-Sang Lee
5Institute of Radiation Medicine, Medical Research Center, Seoul National University Seoul Korea, Republic of
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae Min Jeong
5Institute of Radiation Medicine, Medical Research Center, Seoul National University Seoul Korea, Republic of
1Biomedical Sciences, Seoul National University Seoul Korea, Republic of
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Xie
6Molecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
3Cancer Research Institute, Seoul National University Seoul Korea, Republic of
9Tumor Microenvironment Global Core Research Center, Seoul National University Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
3Cancer Research Institute, Seoul National University Seoul Korea, Republic of
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming-Rong Zhang
6Molecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gi Jeong Cheon
7Department of Nuclear medicine Seoul National University College of Medicine Seoul Korea, Republic of
8Tumor Biology Program, Seoul National University Seoul Korea, Republic of
3Cancer Research Institute, Seoul National University Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

62

Objectives Early diagnosis is a major challenges for rheumatology, and activated macrophages play an important roles in an early rheumatoid arthritis (RA) pathogenesis. Translocator protein (TSPO) is abundant in activated macrophages, thus can be used for the target of biomarker of inflammation. 18F-FEDAC (N-Benzyl-N-methyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl] acetamide) is one of the radiolabeled ligand that recognizes TSPO. In this study, we evaluated the efficacy of 18F-FEDAC as a potential PET tracer for TSPO in a mouse RA model.

Methods RAW 264.7 mouse macrophages were activated with lipopolysaccharide (LPS). Expression level of TSPO mRNA and protein measured by quantitative PCR and western blotting. 18F-FEDAC uptake was measured using gamma counter, and a traditional TSPO ligand PK11195 was used for competition assay. We used collagen induced arthritis (CIA) mouse model as a rheumatoid arthritis animal model for in vivo study. The arthritis incidence was evaluated using an appearance of mouse paws and 99mTc-MDP SPECT/CT. Small animal PET/CT images were acquired using 500 μCi 18F-FEDAC, and PK11195 was 10 minutes pretreated for blocking. We performed H&E staining and TSPO targeted immune fluorescence in normal and arthritic mouse paw tissues.

Results mRNA and protein levels of TSPO expression were 3.9 fold and 2.3 fold higher in activated RAW 264.7 than inactivated RAW 264.7. Uptake of 18F-FEDAC in activated RAW 264.7 cells was 1.5 fold higher than that in non-activated cells. In addition, uptake of 18F-FEDAC in activated RAW 264.7 was successfully blocked by a PK11195. In CIA model, swelling was started 28 days after modeling and fully swelled around at 40 days after modeling. In 99mTc-MDP SPECT images also showed high signals in inflammatory paws. At 1 h after injection of 18F-FEDAC, radiotracer uptake in arthritic paws were significantly increased at 2 to 3 folds more than that in normal paws. PK11195 also successfully blocked in in vivo images. In arthritic mouse paw tissue showed cartilage damages and cells infiltration in bone tissues. The TSPO expression was higher in arthritic paw tissue than normal one.

Conclusions We demonstrated a specific binding of 18F-FEDAC to activated macrophages which have abundant TSPO. 18F-FEDAC PET/CT showed strong uptake in arthritis areas. Our results indicated that 18F-FEDAC-PET images have a potential to visualize RA activity by targeting TSPO.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Visualization of activated macrophages using a translocator protein ligand, 18F-FEDAC, in a rheumatoid arthritis model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Visualization of activated macrophages using a translocator protein ligand, 18F-FEDAC, in a rheumatoid arthritis model
Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, Lin Xie, June-Key Chung, Keon Wook Kang, Ming-Rong Zhang, Gi Jeong Cheon
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 62;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Visualization of activated macrophages using a translocator protein ligand, 18F-FEDAC, in a rheumatoid arthritis model
Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, Lin Xie, June-Key Chung, Keon Wook Kang, Ming-Rong Zhang, Gi Jeong Cheon
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 62;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

CMIIT Young Investigator Award

  • Self-assembled NIR-II dye conjugated small peptides for bone imaging
  • Image-guided cancer surgery using a novel nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging
Show more CMIIT Young Investigator Award

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire